EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

IL-17A/CEBPβ/OPN/LYVE-1 axis inhibits anti-tumor immunity by promoting tumor-associated tissue-resident macrophages

Lei Zhao, Zonghan Wang, Yuying Tan, Jianan Ma, Wei Huang, Xiaoying Zhang, Chunhui Jin, Ting Zhang, Wentao Liu, Yong-Guang Yang

Cell Reports · 2024-12 · 43 (12) · 115039

DOI: 10.1016/j.celrep.2024.115039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024-12. Verfasst von Lei Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, The First Hospital of Jilin University, Changchun, China; Nation…. Hauptthemen laut MEDLINE: Interleukin-17, Osteopontin, Tumor-Associated Macrophages, CCAAT-Enhancer-Binding Protein-beta. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Jilin Provincial Natural Science Foundation, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-associated macrophages (TAMs) are a critical component of the immunosuppressive tumor microenvironment, comprising monocyte-derived macrophages (MDM-TAMs) and tissue-resident macrophages (TRM-TAMs). Here, we discovered that TRM-TAMs mediate the pro-tumor effects of interleukin (IL)-17A and that IL-17A-driven tumor progression requires tumor cell production of osteopontin (OPN). Mechanistically, we identified CEBPβ as a transcription factor downstream of IL-17A in tumor cells and LYVE-1 as an OPN receptor on TRM-TAMs. IL-17A stimulates tumor cell production of OPN, and OPN/LYVE-1 signaling activates the JNK/c-Jun pathway, leading to the proliferation of immunosuppressive LYVE-1+ TRM-TAMs. Unlike its effect on LYVE-1+ TRM-TAMs, OPN interacts with α4β1 to promote the chemotaxis of LYVE-1- MDM-TAMs toward tumors. IL-17A neutralization, OPN inactivation in tumor cells, or LYVE-1 deletion in macrophages inhibited TAMs and enhanced anti-tumor immune responses and anti-PDL1 therapy. Thus, the IL-17A/CEBPβ/OPN/LYVE-1 axis offers a mechanism suppressing anti-tumor immune responses and, hence, an effective therapeutic target for cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-17OsteopontinTumor-Associated MacrophagesCCAAT-Enhancer-Binding Protein-betaAnimalsMiceHumansMice, Inbred C57BLTumor MicroenvironmentCell Line, TumorSignal TransductionNeoplasmsMacrophages

Stichwörter der Autor:innen

CEBPβCP: CancerCP: ImmunologyIL-17ALYVE-1cancer immunotherapymonocyte-derived macrophageosteopontintissue-resident macrophagetriple-negative breast cancertumor microenvironmenttumor-associated macrophage

Substanzen

Interleukin-17OsteopontinCCAAT-Enhancer-Binding Protein-betaCebpb protein, mouse

Autor:innen und Institutionen

  • Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, The First Hospital of Jilin University, Changchun, China; National-local Joint Engineering Laboratory of Animal Models for Human Disea…

Förderung

  • National Natural Science Foundation of China
  • Jilin Provincial Natural Science Foundation
  • National Key Research and Development Program of China
  • JiangXi Province Human Resources and Social Security Department
  • Key Technologies Research and Development Program

Zitieren

APA

Zhao, L., Wang, Z., Tan, Y., Ma, J., Huang, W., Zhang, X., Jin, C., Zhang, T., Liu, W., & Yang, Y. G. (2024). IL-17A/CEBPβ/OPN/LYVE-1 axis inhibits anti-tumor immunity by promoting tumor-associated tissue-resident macrophages. Cell Reports, 43(12), 115039. https://doi.org/10.1016/j.celrep.2024.115039

Vancouver

Zhao L, Wang Z, Tan Y, Ma J, Huang W, Zhang X, et al. IL-17A/CEBPβ/OPN/LYVE-1 axis inhibits anti-tumor immunity by promoting tumor-associated tissue-resident macrophages. Cell Reports. 2024;43(12):115039. doi:10.1016/j.celrep.2024.115039

BibTeX
@article{Zhao2024,
  author = {Zhao, Lei and Wang, Zonghan and Tan, Yuying and Ma, Jianan and Huang, Wei and Zhang, Xiaoying and Jin, Chunhui and Zhang, Ting and Liu, Wentao and Yang, Yong-Guang},
  title = {IL-17A/CEBPβ/OPN/LYVE-1 axis inhibits anti-tumor immunity by promoting tumor-associated tissue-resident macrophages},
  journal = {Cell Reports},
  year = {2024},
  volume = {43},
  number = {12},
  pages = {115039},
  doi = {10.1016/j.celrep.2024.115039}
}
Kostenlos starten →